O. Maíz

2.0k total citations
32 papers, 411 citations indexed

About

O. Maíz is a scholar working on Rheumatology, Ophthalmology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, O. Maíz has authored 32 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 12 papers in Ophthalmology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in O. Maíz's work include Ocular Diseases and Behçet’s Syndrome (12 papers), Systemic Lupus Erythematosus Research (9 papers) and Vasculitis and related conditions (7 papers). O. Maíz is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (12 papers), Systemic Lupus Erythematosus Research (9 papers) and Vasculitis and related conditions (7 papers). O. Maíz collaborates with scholars based in Spain, United States and Japan. O. Maíz's co-authors include Joaquín Belzunegui, Ricardo Blanco, Alfredo Adán, Manuel Figueroa, Marina Mesquida, Carlos González, Rubén Queiró, J. R. De Dios, Miguel Á. González‐Gay and José L. Hernández and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

O. Maíz

28 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Maíz Spain 9 217 200 106 63 59 32 411
Haroldo Vieira de Moraes Brazil 15 121 0.6× 305 1.5× 31 0.3× 32 0.5× 127 2.2× 43 599
Seiji Sugiura Japan 7 128 0.6× 158 0.8× 41 0.4× 56 0.9× 47 0.8× 11 359
D Djawari Germany 9 135 0.6× 220 1.1× 35 0.3× 105 1.7× 93 1.6× 44 418
Laura Pelegrín Spain 17 224 1.0× 711 3.6× 67 0.6× 118 1.9× 52 0.9× 49 825
Maria Pia Pirraglia Italy 15 136 0.6× 459 2.3× 56 0.5× 60 1.0× 120 2.0× 27 582
Ariel Schlaen Argentina 12 201 0.9× 621 3.1× 33 0.3× 100 1.6× 78 1.3× 41 690
Min Ju Choi South Korea 10 48 0.2× 87 0.4× 26 0.2× 50 0.8× 94 1.6× 22 287
Ali Tahsin Güneş Türkiye 15 79 0.4× 34 0.2× 12 0.1× 132 2.1× 61 1.0× 43 519
İlknur Tuğal Tutkun Türkiye 5 108 0.5× 252 1.3× 29 0.3× 98 1.6× 34 0.6× 10 328
Vivien M. Tham United States 10 84 0.4× 466 2.3× 9 0.1× 56 0.9× 150 2.5× 14 638

Countries citing papers authored by O. Maíz

Since Specialization
Citations

This map shows the geographic impact of O. Maíz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Maíz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Maíz more than expected).

Fields of papers citing papers by O. Maíz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Maíz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Maíz. The network helps show where O. Maíz may publish in the future.

Co-authorship network of co-authors of O. Maíz

This figure shows the co-authorship network connecting the top 25 collaborators of O. Maíz. A scholar is included among the top collaborators of O. Maíz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Maíz. O. Maíz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Medina, Miguel Ángel, et al.. (2025). Hemophagocytic Lymphohistiocytosis in a Kidney Transplant Recipient: Case Report. Transplantation Proceedings. 57(1). 90–92.
2.
Loricera, J., O. Maíz, Eugenio de Miguel, et al.. (2025). Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice. Seminars in Arthritis and Rheumatism. 71. 152640–152640.
3.
Blanco, Ricardo, O. Maíz, Susana Romero-Yuste, et al.. (2024). Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases. Lara D. Veeken. 64(5). 2928–2936. 3 indexed citations
4.
Loricera, J., D. Prieto-Peña, Susana Romero-Yuste, et al.. (2024). Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature. Arthritis Research & Therapy. 26(1). 116–116. 5 indexed citations
5.
Loricera, J., Javier Narváez, O. Maíz, et al.. (2024). Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis. European Journal of Internal Medicine. 129. 78–86. 7 indexed citations
6.
7.
8.
9.
Vives, Cristina Goena, et al.. (2022). Heart Transplantation in Systemic Sclerosis: A Therapeutic Option. Presentation of a Case and Literature Review. Reumatología Clínica (English Edition). 18(6). 374–376. 1 indexed citations
10.
Vives, Cristina Goena, et al.. (2021). Heart Transplantation in Systemic Sclerosis: A Therapeutic Option. Presentation of a Case and Literature Review. Reumatología Clínica. 18(6). 374–376. 3 indexed citations
11.
Palmou‐Fontana, Natalia, V. Calvo-Río, J. L. Martín-Varillas, et al.. (2018). Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.. PubMed. 36(4). 652–657. 26 indexed citations
12.
Hernández, M.V., Marina Mesquida, Maite Sáinz de la Maza, et al.. (2017). THU0381 Certolizumab pegol is effective in uveitis associated to spondyloarthritis refractory to other tumour necrosis factor inhibitors. Annals of the Rheumatic Diseases. 76. 350–350. 5 indexed citations
13.
Calvo-Río, V., O. Maíz, E. Beltrán, et al.. (2017). AB0337 Biologic therapy in severe peripheral ulcerative keratitis (PUK). multicenter study of 27 patients. Annals of the Rheumatic Diseases. 76. 1166–1167. 1 indexed citations
14.
15.
Calvo-Río, V., M. Santos-Gόmez, Inmaculada Calvo, et al.. (2016). Anti–Interleukin‐6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty‐Five Patients. Arthritis & Rheumatology. 69(3). 668–675. 104 indexed citations
16.
Llorenç, Víctor, Marina Mesquida, Maite Sáinz de la Maza, et al.. (2014). Certolizumab Pegol, a New Anti-TNF-α in the Armamentarium against Ocular Inflammation. Ocular Immunology and Inflammation. 24(2). 167–172. 40 indexed citations
17.
18.
Queiró, Rubén, O. Maíz, J. R. De Dios, et al.. (2000). Subclinical Sacroiliitis in Inflammatory Bowel Disease: A Clinical and Follow-up Study. Clinical Rheumatology. 19(6). 445–449. 72 indexed citations
19.
Belzunegui, Joaquín, et al.. (1997). Hydatid disease of bone with adjacent joint involvement. A radiological follow-up of 12 years. Lara D. Veeken. 36(1). 133–135. 33 indexed citations
20.
Belzunegui, Joaquín, et al.. (1997). Leg pain with a periosteal and endosteal reaction. Arthritis & Rheumatism. 40(2). 385–387. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haroldo Vieira de Moraes Breakdown of academic impact, for papers by Seiji Sugiura Breakdown of academic impact, for papers by D Djawari Breakdown of academic impact, for papers by Laura Pelegrín Breakdown of academic impact, for papers by Maria Pia Pirraglia Breakdown of academic impact, for papers by Ariel Schlaen Breakdown of academic impact, for papers by Min Ju Choi Breakdown of academic impact, for papers by Ali Tahsin Güneş Breakdown of academic impact, for papers by İlknur Tuğal Tutkun Breakdown of academic impact, for papers by Vivien M. Tham
Rankless by CCL
2026